We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Instant Diagnosis Is Still Increasing
Industry Insight

Instant Diagnosis Is Still Increasing

Instant Diagnosis Is Still Increasing
Industry Insight

Instant Diagnosis Is Still Increasing


Want a FREE PDF version of This Industry Insight?

Complete the form below and we will email you a PDF version of "Instant Diagnosis Is Still Increasing"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

It’s reported that the instant diagnosis will reach 18.7 billion dollars! News is based on the data of some consulting agencies. As is known, with the prevalence of chronic diseases and infectious diseases, a faster diagnostic method is extremely necessary, which indirectly gives birth to the occurrence of modern diagnostic techniques.

On the basis of efficient algorithms, some advanced diagnostic technologies can effectively diagnose those prognostic diseases with specificity and sensitivity. In addition, the promotion of precise medical items has brought a rapid growth in precise diagnosis, as well as the instant diagnosis. It is still increasing. Nowadays, instant diagnosis has played an important role in clinical application such as POCT. POCT is widely used in oral anticoagulant detection, anti-platelet drug selection, the field of microbiology and drug detection, and especially the diagnosis of cardiovascular disease.

Recently, the field of instant diagnosis is becoming increasing wide; it has extended to medical health, agriculture, forestry, food testing, environment, and so on. Generally, people call it biological emergency management. Certainly, in terms of instant diagnosis, blood diagnosis is still the main focus, which could bring increasing growths. However, some new growth points have appeared recently, including HIV/AIDS, tuberculosis, hepatitis, HPV and other infectious diseases. Among these new growth points, handheld blood glucose meter detection device is the most potential.

It’s also reported that instant diagnosis is expected to widen its international market in Asia-Pacific areas, which might make the values reach 530 million dollars. Growth in emerging markets is mainly from health care reform, economic prosperity and aging population. It’s noted that instant diagnosis generally focuses on the following product categories: infectious diseases, cardiac markers, hematology, coagulation, OTC fertility test, clinical chemistry, etc.. It shows a fact that instant diagnosis will lead the medical market to a new era.

About Creative Peptides
Creative Peptides is specialized in the process development and the manufacturing of bioactive peptides. The goal is to offer a high-quality service for all the peptide development and manufacturing needs. Visit http://www.creative-peptides.com/services/custom-gmp-peptide-synthesis-services.html to know more about Creative Peptides.
Advertisement